Literature DB >> 8645309

Characterization of component-I gene of botulinum C2 toxin and PCR detection of its gene in clostridial species.

N Fujii1, T Kubota, S Shirakawa, K Kimura, I Ohishi, K Moriishi, E Isogai, H Isogai.   

Abstract

Botulinum C2 toxin is composed of two nonlinked protein components, component-I (light chain) and component-II (heavy chain). It is produced by Clostridium botulinum types C and D, and is thought to play a lethal pathogenic role. These biological activities of C2 toxin may be due to the ADP-ribosylation of non-muscle actin by component-I of the toxin. We were able to isolate two overlapping gene fragments encoding component-I from the chromosomal DNA of Clostridium botulinum type C strain (C)-203U28, and determine the complete nucleotide sequence of component-I gene. The gene for component-I, bc21, consists of one open reading frame (ORF) encoding 431 amino acid residues (1293 nucleotides) without signaling peptide sequence. The molecular mass calculated from the deduced amino acid sequence was 49400.37 Da. Mono-ADP-ribosyltransferase activity was demonstrated in the lysate from E. coli transformed by the recombinant plasmid, pGEM-C2 encompassing whole component-I gene with its own promoter.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8645309     DOI: 10.1006/bbrc.1996.0409

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  14 in total

1.  Mapping the lethal factor and edema factor binding sites on oligomeric anthrax protective antigen.

Authors:  Kristina Cunningham; D Borden Lacy; Jeremy Mogridge; R John Collier
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-07       Impact factor: 11.205

2.  Molecular analysis of an extrachromosomal element containing the C2 toxin gene discovered in Clostridium botulinum type C.

Authors:  Yoshihiko Sakaguchi; Tetsuya Hayashi; Yumiko Yamamoto; Keisuke Nakayama; Kai Zhang; Shaobo Ma; Hideyuki Arimitsu; Keiji Oguma
Journal:  J Bacteriol       Date:  2009-03-06       Impact factor: 3.490

3.  Binding and internalization of Clostridium botulinum C2 toxin.

Authors:  Masahiro Nagahama; Tohko Hagiyama; Takashi Kojima; Kouhei Aoyanagi; Chihiro Takahashi; Masataka Oda; Yoshihiko Sakaguchi; Keiji Oguma; Jun Sakurai
Journal:  Infect Immun       Date:  2009-08-31       Impact factor: 3.441

4.  Clostridium perfringens iota-toxin requires activation of both binding and enzymatic components for cytopathic activity.

Authors:  M Gibert; L Petit; S Raffestin; A Okabe; M R Popoff
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

5.  A human-food web-animal interface on the prevalence of food-borne pathogens (Clostridia and Enterococcus) in mixed veterinary farms.

Authors:  A Prisilla; M Deena Remin; B Roja; P Chellapandi
Journal:  Food Sci Biotechnol       Date:  2019-03-16       Impact factor: 2.391

6.  Functional characterization of an extended binding component of the actin-ADP-ribosylating C2 toxin detected in Clostridium botulinum strain (C) 2300.

Authors:  Charlott Sterthoff; Alexander E Lang; Carsten Schwan; Andreas Tauch; Klaus Aktories
Journal:  Infect Immun       Date:  2010-02-09       Impact factor: 3.441

7.  Molecular Evolutionary Constraints that Determine the Avirulence State of Clostridium botulinum C2 Toxin.

Authors:  A Prisilla; R Prathiviraj; P Chellapandi
Journal:  J Mol Evol       Date:  2017-04-05       Impact factor: 2.395

8.  The N-terminal part of the enzyme component (C2I) of the binary Clostridium botulinum C2 toxin interacts with the binding component C2II and functions as a carrier system for a Rho ADP-ribosylating C3-like fusion toxin.

Authors:  H Barth; F Hofmann; C Olenik; I Just; K Aktories
Journal:  Infect Immun       Date:  1998-04       Impact factor: 3.441

Review 9.  Binary bacterial toxins: biochemistry, biology, and applications of common Clostridium and Bacillus proteins.

Authors:  Holger Barth; Klaus Aktories; Michel R Popoff; Bradley G Stiles
Journal:  Microbiol Mol Biol Rev       Date:  2004-09       Impact factor: 11.056

10.  A recombinant fusion toxin based on enzymatic inactive C3bot1 selectively targets macrophages.

Authors:  Lydia Dmochewitz; Christina Förtsch; Christian Zwerger; Martin Vaeth; Edward Felder; Markus Huber-Lang; Holger Barth
Journal:  PLoS One       Date:  2013-01-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.